P

Psybio Therapeutics Corp
OTC:PSYBF

Watchlist Manager
Psybio Therapeutics Corp
OTC:PSYBF
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 943.1k USD

Net Margin
Psybio Therapeutics Corp

0%
Current
0%
Average
3.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-4.1m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Psybio Therapeutics Corp
Glance View

Market Cap
943.1k USD
Industry
N/A

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-02-08. The firm is developing a new class of drugs intended for the treatment of mental health challenges and other disorders. The firm is in the process of developing its portfolio of product candidates for sale in the pharmaceutical industry. The company has developed a technology platform that enables the generation of its formulation for its lead compound psilocybin, biosynthetic psilocybin, and other targeted tryptamines through a biosynthetic process using genetically modified bacteria through collaboration with Miami University-based in Oxford, Ohio. The firm utilizes a bio-medicinal chemistry approach to therapeutic development, in which psychoactive compounds can be utilized as a template upon, which to develop precursors and analogs, both naturally and non-naturally occurring.

PSYBF Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-4.1m
/
Revenue
0
What is the Net Margin of Psybio Therapeutics Corp?

Based on Psybio Therapeutics Corp's most recent financial statements, the company has Net Margin of 0%.

Back to Top